Maki Clinic Nagoya: Low-Dose Immune Checkpoint Inhibitors & Combined Cell Therapy
Medical Supporter — Information Notice
This article is a summary of international medical information and is not medical advice; it cannot replace the diagnosis or treatment plan of your attending physician. The medical technologies, drug information and clinical data presented here are compiled from public literature and official statements of major Japanese medical institutions; the applicability and outcome of any therapy vary with each patient and must be assessed individually by a qualified physician.
Located in Nagoya, Aichi Prefecture, Maki Clinic is renowned for its "precise and economical" approach to immunotherapy. Director Maki discovered as early as 2015 that immune checkpoint inhibitors can trigger sufficient immune responses at specific low doses, without necessarily requiring standard high-dose administration.
Innovative Strategy: Ultra-Low Dose Administration
The standard recommended dose for Opdivo (Nivolumab) is 240mg, which is costly and carries higher risks of side effects. Maki Clinic's specialty lies in:
- 20mg Ultra-Low Dose: Clinical research indicates that using only 6%~10% of the standard dose can effectively block the PD-1 pathway.
- Significant Side Effect Reduction: Low-dose administration helps avoid excessive immune system attacks on healthy organs, reducing the risk of serious complications like interstitial pneumonia.
- Reduced Financial Burden: Medical expenses are a fraction of standard therapies, making long-term nurturing care sustainable for patients.
1+1>2: Combined Cell Therapy
Beyond low-dose medications, Maki Clinic excels in "combination techniques":
- NK Cell Therapy: First, use medication to unmask cancer cells, then introduce highly active NK cells to eliminate them.
- iNKT (Fourth Type of Lymphocyte) Therapy: Activates the rare but powerful immune-regulating cells in the human body for more durable anti-cancer effects.
Professional Expertise and Recognition
Director Maki has extensive experience treating over 150 patients with advanced cancer. The clinic's data has been validated in international medical journals, such as clinical studies published in India in 2022. The Medical Supporter team recommends Maki Clinic for those seeking "precision strikes" while maintaining a high quality of life during long-term cancer nurturing care.
【Medical Supporter Guardian Statement】 Medical Supporter was formerly certified as a medical visa guarantor by Japan's Ministry of Foreign Affairs and the Ministry of Economy, Trade and Industry (B-066).
Considering medical care in Japan? Need information and support?
We help you organize the information needed for medical travel to Japan, liaise with Japanese medical institutions, and arrange a second-opinion consultation.The first consultation is free; an advisor will help you clarify the next steps.